National Ivory Action Plan Process
EIA recommendations for the 77th meeting of the CITES Standing Committee
EIA recommendations for the 77th meeting of the CITES Standing Committee
Article XIII of the CITES Convention is an important provision to encourage remedial actions by Parties found to be inadequately implementing the Convention. EIA has prepared an analysis of key compliance matters in key countries China, DRC, Lao PDR and Nigeria given their persistent non-compliance and/or significant roles in wildlife trafficking globally.
Learn more about focal issues that EIA’s Wildlife Campaign aims to discuss during SC77.
Japan’s elephant ivory market is open – the legal framework for the control of the trade in ivory is designed and built to regulate and facilitate commercial ivory trade and support ivory traders.
Illegal wildlife trade is happening on a large scale to supply the parts and products of protected species such as leopards, pangolins, rhinos and tigers to serve as ingredients in some traditional Chinese medicines – and some big international household names are invested
EIA’s research, conducted over the past two years, reveals the continued online availability of at least 88 traditional Chinese medicine (TCM) products stated to contain leopard, pangolin and, in a few cases, tiger and rhino, manufactured by 72 Chinese companies which have been licensed by the National Medical Products Administration of China.